IRWD icon

Ironwood Pharmaceuticals

220 hedge funds and large institutions have $672M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

5.78% less ownership

Funds ownership: 107.87%102.09% (-5.8%)

15% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 46

40% less capital invested

Capital invested by funds: $1.12B → $672M (-$445M)

Holders
220
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46.4M
Puts
$50K
Net Calls
Net Calls Change

Top Sellers

1 -$16.8M
2 -$9.1M
3 -$8.61M
4
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$6.37M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.34M
52
$1.33M
53
$1.32M
54
$1.3M
55
$1.28M
56
$1.26M
57
$1.23M
58
$1.15M
59
$1.14M
60
$1.11M
61
$1.01M
62
$898K
63
$893K
64
$868K
65
$858K
66
$853K
67
$813K
68
$767K
69
$748K
70
$704K
71
$699K
72
$692K
73
$689K
74
$672K
75
$657K